Top Markets
Coin of the day
PhaseRx, Inc. PhaseRx, Inc.

PhaseRx, Inc.

PZRXQ
株式のランク #42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$1.17K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 PhaseRx, Inc. (PZRXQ)

カテゴリー

PhaseRx, Inc.(PZRXQ)の配当利回りの履歴
PhaseRx, Inc.(銘柄コード: PZRXQ)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
PhaseRx, Inc.(PZRXQ)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)